Changes in pulse pressure, heart rate and the pulse pressure x heart rate product during squatting in Type 1 diabetes according to age

Diabetic Medicine : a Journal of the British Diabetic Association
J-C PhilipsAndré J Scheen

Abstract

We assessed changes in pulse pressure and heart rate during a squatting test, as indirect markers of arterial stiffness and cardiovascular autonomic neuropathy, respectively, according to age and sex in patients with Type 1 diabetes mellitus. We evaluated 160 diabetic patients, divided into four groups of 20 men and 20 women according to age (G1, 20-30 years old; G2, 31-40 years old; G3, 41-50 years old; and G4, 51-60 years old), and 160 non-diabetic matched control subjects. Each subject underwent a 3 min posture test (standing-squatting-standing) with continuous measurement of arterial blood pressure and heart rate by a Finapres device. Overall values throughout the test, baseline levels in initial standing position and squatting-induced changes in pulse pressure, heart rate and the pulse pressure x heart rate product were compared between diabetic patients and healthy control subjects. In the standing position, a greater increase in pulse pressure and lower reduction in heart rate with age led to a significantly higher pulse pressure x heart rate product in diabetic patients compared with control subjects. In the squatting position, a more marked pulse pressure increase in the absence of appropriate reduction in heart rate r...Continue Reading

References

Apr 29, 1999·Diabetic Medicine : a Journal of the British Diabetic Association·A R AhlgrenT Länne
Feb 5, 2002·American Journal of Hypertension·Ian B WilkinsonJohn R Cockcroft
Aug 27, 2002·Journal of Hypertension·Miranda T SchramCoen D Stehouwer
Apr 30, 2003·Diabetes Care·Aaron I VinikRoy Freeman
May 15, 2003·American Journal of Hypertension·Pierre LaurentMichel E Safar
Jul 29, 2003·European Journal of Applied Physiology·Caroline A Rickards, David G Newman
Nov 5, 2003·Journal of Hypertension·Athanase Benetos
Nov 5, 2003·Journal of Hypertension·Miranda T SchramUNKNOWN EURODIAB Prospective Complications Study Group
Jan 14, 2004·Clinical Physiology and Functional Imaging·Craig D SteinbackJ Kevin Shoemaker
Apr 17, 2004·Seminars in Neurology·Aaron I VinikTomris Erbas
May 7, 2004·Current Hypertension Reports·Michel E Safar
Aug 25, 2004·Circulation·Mats RönnbackUNKNOWN Finnish Diabetic Nephropathy (FinnDiane) Study Group
Dec 25, 2004·Diabetologia·D R WitteUNKNOWN EURODIAB Prospective Complications Study Group
Apr 27, 2005·Hypertension·Miranda T SchramUNKNOWN EURODIAB Prospective Complications Study Group
Nov 1, 2006·Advances in Cardiology·Jacques Amar, Bernard Chamontin
Jun 22, 2007·Clinical and Experimental Pharmacology & Physiology·James D Cameron, J Kennedy Cruickshank
Aug 30, 2007·American Journal of Physiology. Endocrinology and Metabolism·Andrew J SommerfieldBrian M Frier
Nov 6, 2007·Diabetes Care·Jean-Christophe PhilipsAndré J Scheen
Apr 1, 2008·Diabetes Care·Sabita S Soedamah-MuthuUNKNOWN EURODIAB Prospective Complications Study Group
Apr 23, 2008·Hypertension·Carmel M McEnieryUNKNOWN Anglo-Cardiff Collaborative Trial Investigators
Dec 3, 2008·Diabetic Medicine : a Journal of the British Diabetic Association·M NakagawaT Saikawa
May 14, 2009·Diabetes/metabolism Research and Reviews·J C PhilipsA J Scheen
Jul 3, 2009·Metabolism: Clinical and Experimental·Baqiyyah ConwayTrevor J Orchard
Jul 8, 2009·Atherosclerosis·Anna TahvanainenIlkka Pörsti
Oct 14, 2009·Transplant International : Official Journal of the European Society for Organ Transplantation·Marcus BaumannUwe Heemann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.